All Stories

  1. Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer

    Article • Journal of Experimental & Clinical Cancer Research, November 2018, Springer Science + Business Media

    Dr Gamal Eldein Fathy Abd-Ellatef Abd-Elrahman

  2. Investigating the role of miRNA-98 and miRNA-214 in chemoresistance of HepG2/Dox cells: studying their effects on predicted ABC transporters targets

    Article • Medicinal Chemistry Research, September 2017, Springer Science + Business Media

    Dr Gamal Eldein Fathy Abd-Ellatef Abd-Elrahman

  3. Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance

    Article • ACS Medicinal Chemistry Letters, February 2017, American Chemical Society (ACS)

    Dr Gamal Eldein Fathy Abd-Ellatef Abd-Elrahman

  4. Ulva lactuca polysaccharides prevent Wistar rat breast carcinogenesis

    Article • Breast Cancer Targets and Therapy, February 2017, Dove Medical Press

    Dr Gamal Eldein Fathy Abd-Ellatef Abd-Elrahman, Prof. Dr. Osama M Ahmed, prof Abdel-Hamid Zaki Abdel-Hamid

  5. Differential effects of c-myc and ABCB1 silencing on reversing drug resistance in HepG2/Dox cells

    Article • Tumor Biology, November 2015, Springer Science + Business Media

    Dr Gamal Eldein Fathy Abd-Ellatef Abd-Elrahman